Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allakos, AM-Pharma, Anavex, Arcutis, Aviceda, Chipscreen Newway, Hope Medicines, Kairos, Sarepta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Renovion.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bridgebio, Chiesi, Dermavant, Elicio, Indapta, Zai Lab.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aclaris, Aim Immunotech, Alcon, Alkeus, Aviceda, Bio-Path, Cantargia, Constant, Eyepoint, Junshi, Marius, Spago, Taysha, Teva, Valneva, Vyne.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affimed, Atea, Biomedical Research & Bio-Products, Elicio, Innovent, Ironwood, Medicenna, Neuraptive, NGM, Novocure, Renibus, Summit, Theracosbio, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aegle, Bayer, Biomea, Biora, Clene, Curevo, Cybin, Fate, Highfield, Novartis, Novo Nordisk, Okyo, Oncternal, Oryzon, Pepgen, Pulmatrix, Tiziana, Vertex, Vincerx, Xilio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Applied, Asklepios, Boston, Curevac, Deciphera, Delta-Fly, Kiromic, Merck, Newron, Orion, Rivus, Verrica.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alimera, Genascence, Glycomimetics, GPN, Immutep, Inflarx, Kynexis, Lyndra, Rhythm, Sitryx, Soligenix, Starton, Tango, Tryp.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Agios, Alkermes, Alvotech, Anavex, Athira, Belief, Chemomab, Cymabay, Dyne, Genascence, Keros, Maplight, Ocuterra, Recode, Regulus, Salarius, Sciwind, Therapeutic Solutions, Upstream, Ultragenyx, Ventus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atai, Avenue, Citius, Diakonos, Gannex, Inmune, Innovent, Inventprise Jiangsu Recbio, Leap, South Rampart, Spero, Stuart.